BRIEF-Aerie Pharma's Roclatan succeeds in second late-stage study
* Aerie pharmaceuticals reports positive roclatan™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% phase 3 topline efficacy results
Jan 5 (Reuters) -
* MSNBC- Veteran broadcaster Greta Van Susteren will join MSNBC
NEW YORK, May 24 U.S. stocks ended up slightly on Wednesday, with the S&P 500 hitting a record high close, after minutes of the Federal Reserve's latest meeting showed policymakers view a rate hike coming soon.